Neuro Pathways: A Cleveland Clinic Podcast for Medical Professionals

Neuro Pathways: A Cleveland Clinic Podcast for Medical Professionals


Ketamine Research for Treatment-Resistant Depression (Early Work Through Current State)

November 01, 2020

Roughly one in 10 Americans takes an antidepressant to aid in the debilitating symptoms of clinical depression, but for some medications don’t work. In this episode, Amit Anand, MD, discusses the evolving therapies for treatment-resistant depression, including ketamine and esketamine.